scholarly article | Q13442814 |
P50 | author | Maurizio Zazzi | Q28743821 |
Stefano Rusconi | Q40213049 | ||
Antonio Di Biagio | Q41372289 | ||
Alessio Signori | Q42684924 | ||
Laura Monno | Q56487067 | ||
Andrea De Luca | Q57977169 | ||
P2093 | author name string | Bianca Bruzzone | |
Irene Schiavetti | |||
Grazia Punzi | |||
Giovanni Penco | |||
ARCA Collaborative Group | |||
Angela Marzocchetti | |||
Maria Grazia Colao | |||
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy | Q34003391 | ||
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study | Q34481365 | ||
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial | Q34664004 | ||
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response | Q34684386 | ||
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results | Q35214141 | ||
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
Web resources for HIV type 1 genotypic-resistance test interpretation | Q36899999 | ||
Impact of pre-therapy viral load on virological response to modern first-line HAART. | Q38427973 | ||
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy | Q38460522 | ||
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults | Q39685276 | ||
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy | Q44506169 | ||
Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA). | Q44962177 | ||
Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis | Q45024810 | ||
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials | Q45414505 | ||
Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy | Q45709333 | ||
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. | Q46900196 | ||
Surrogate Markers for Disease Progression in Treated HIV Infection | Q56830875 | ||
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥ 200 cells/μl | Q57259705 | ||
A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study | Q57877926 | ||
An Immunological Comparison of Third Companion in Advanced Drug-Naive HIV-Infected Patients | Q57997508 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | drug resistance | Q12147416 |
P1104 | number of pages | 8 | |
P304 | page(s) | 1648-1655 | |
P577 | publication date | 2014-07-11 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy | |
P478 | volume | 86 |
Q38619193 | Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects |
Q64060835 | INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels |
Q51746832 | Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy. |
Q69682379 | Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study |
Q39412054 | Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy |
Q39648233 | Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens. |
Search more.